Events
inVentiv Advance Insights presentation at the AMCP 22nd Annual Meeting and Showcase
April 9, 2010 San Diego, CAJennifer Restivo, VP and Managing Director, Managed Markets at inVentiv Advance Insights, and Kevin Cast, VP, Pharmaceutical Sales at ESI-Curascript, will discuss Risk Evaluation and Mitigation Strategies (REMS). The podium presentation is scheduled on Friday, April 9, 2:45 PM – 3:45 PM. Please check your program schedule for location.
The session will assess the current and future impact of emerging REMS trends. Jennifer and Kevin will present learnings, based on original research, from manufacturers and payers, as well as provide an overview of key considerations for optimal REMS implementation. Kevin brings expertise from his experience with implementing managed distribution programs at ESI-Curascript. Jennifer provides Managed Markets expertise relevant to REMS programs on behalf of inVentiv Health, which by virtue of its recent acquisition of ParagonRx, has designed or implemented over 40 REMS or risk management programs to date.
Key objectives of the presentation include:
Understanding how payers have, and will, integrate REMS into utilization management practices
Defining the critical factors and collaborative efforts between payers and manufacturers to ensure successful design and execution of REMS
Identifying approaches to minimizing implementation challenges and realizing opportunities for improved REMS execution
We hope you will be able to join us for this presentation. Please feel free to pass this information to colleagues that may be in attendance.
Please also visit us at Booth 1029 in the Showcase.
inVentiv Health provides a spectrum of services for pharmaceutical companies ranging from the managed markets consulting of Advance Insights to the REMS design and implementation expertise of ParagonRx. CuraScript is the specialty pharmacy division of ESI, which has implemented the managed distribution requirements for multiple REMS.
The session will assess the current and future impact of emerging REMS trends. Jennifer and Kevin will present learnings, based on original research, from manufacturers and payers, as well as provide an overview of key considerations for optimal REMS implementation. Kevin brings expertise from his experience with implementing managed distribution programs at ESI-Curascript. Jennifer provides Managed Markets expertise relevant to REMS programs on behalf of inVentiv Health, which by virtue of its recent acquisition of ParagonRx, has designed or implemented over 40 REMS or risk management programs to date.
Key objectives of the presentation include:
Understanding how payers have, and will, integrate REMS into utilization management practices
Defining the critical factors and collaborative efforts between payers and manufacturers to ensure successful design and execution of REMS
Identifying approaches to minimizing implementation challenges and realizing opportunities for improved REMS execution
We hope you will be able to join us for this presentation. Please feel free to pass this information to colleagues that may be in attendance.
Please also visit us at Booth 1029 in the Showcase.
inVentiv Health provides a spectrum of services for pharmaceutical companies ranging from the managed markets consulting of Advance Insights to the REMS design and implementation expertise of ParagonRx. CuraScript is the specialty pharmacy division of ESI, which has implemented the managed distribution requirements for multiple REMS.
Previous page: In The News
